<DOC>
	<DOCNO>NCT00349661</DOCNO>
	<brief_summary>Objectives : A prospective investigation effect omeprazole , proton pump inhibitor , anti-platelet action clopidogrel . The main decision criterion concern change VASP protein phosphorylation treatment . Phosphorylation measure administration omeprazole versus placebo patient undergoing clopidogrel treatment . Type study : Single center , double blind , randomize parallel group study versus placebo , compare two treatment group : - clopidogrel + omeprazole + standard regime ( beta-blockers , atorvastatin , IEC , aspirin ) - clopidogrel + placebo+ standard regime ( beta-blockers , atorvastatin , IEC , aspirin ) Study population : 120 patient Cardiology Department Brest University hospital , Brest ( France ) , receive standard treatment comprise load dose clopidogrel follow daily dose 75 mg associate 75 mg aspirin , randomize 20 mg/day omeprazole 20 mg/day placebo treatment group . The efficacy clopidogrel assess inter-group comparison VASP test . Study period : 7 day ' treatment per patient . Total study period estimate 6 month . Expected finding : The result confirm suspected negative effect omeprazole clopidogrel 's impact arterial thrombosis risk , secondarily allow new recommendation draw association .</brief_summary>
	<brief_title>Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel</brief_title>
	<detailed_description>Preventing recurrence thrombosis follow angioplasty relies dual-therapy associate anti-platelet agent aspirin clopidogrel . This regime keep 1 6 month , depend type stent deploy angioplasty . The biological effectiveness clopidogrel treatment assess VASP test , new platelet test , result show correlate risk thrombosis . A study run recently strongly suggest omeprazole associate poor response clopidogrel . Omeprazole anti-ulcer agent frequently prescribe prevent unwanted side-effects aspirin , make frequently associate clopidogrel aftermath angioplasty . Study population : 120 patient Cardiology Department Brest University hospital , Brest ( France ) , receive standard treatment comprise load dose clopidogrel follow daily dose 75 mg associate 75 mg aspirin , randomize 20 mg/day omeprazole 20 mg/day placebo treatment group . The efficacy clopidogrel assess inter-group comparison VASP test . Study period : 7 day ' treatment per patient . Total study period estimate 6 month .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>patient indication aspirin clopidogrel treatment patient &lt; 18 year liver disease drug elute stent gastrointestinal ulcus bleeding pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>clopidogrel</keyword>
	<keyword>omeprazole</keyword>
</DOC>